Press Release

Global Chronic Lower Back Pain Market to Reach USD4.7 Billion by 2030 Due to Growing Elderly Population

The Global Chronic Lower Back Pain Market size was valued at around USD2.8 billion in 2024 and is projected to reach USD4.7 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The global rise in chronic lower back pain is significantly influenced by multiple factors such as increasing awareness and the aging population. As per, the World Health Organization, older adults experience lower back is one of the main disability in adults aged 60 years and over that is mainly influenced by pain resulting from a spine degenerative nature. For example, as per an NIH report, in 2021, about 80% of older adults, experience some sort of lower back pain during their lives, and at any time, 25% of them have severe back pain. Lifting loads in the wrong way is one of the common causes of back pain and injuries. The position is very important while seating and maintaining proper posture and make it a habit to sit up straight without slouching.

Besides, increased awareness about diseases and good healthcare facilities have led to early diagnoses and further greater demand for effective treatments. Governments across the globe have implemented different programs like Postural awareness and the need for attention regulation postural awareness these types of programs help to overcome muscle tension movement.

Other efficient non-pharmacologic therapies in controlling chronic lower back pain would be without medication. Physical therapy, one of the most frequently used treatment modalities, allows improvement in posture, muscle strengthening, and pain decrease. Meditation and mindfulness decrease tension and the sensitivity of pain. Sophisticated methods such as laser therapy have been employed to treat and diminish inflammation in the affected area. These treatments provide holistic benefits to help the patient handle the pain with their natural capacity and improve overall well-being, further states the research report, “Global Chronic Lower Back Pain Market Analysis, 2025”

Global Chronic Lower Back Pain Market Segmentation Analysis 

The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment Holds a Major Market Share

Based on the drug class, the market is further bifurcated into Non-steroidal anti-inflammatory Drugs (NSAIDs), Opioids, Analgesics, Antidepressants, and others. Out of them, non-steroidal anti-inflammatory Drugs (NSAIDs) hold the largest market share about 55%. These drugs are the most prescribed medications. Most are used for arthritis and other musculoskeletal diseases to control pain and inflammation. They are the most common drug used by adults, readily available on the counter, and provide long-term relief from pain. For example, based on the study conducted by Harvard Health Publishing over 80% of people are going to be treated in hospitals for back pains at some point in their lifetime, hence non-steroidal anti-inflammatories are the primary choices among the consumers for relief of pain.

North America at the Forefront of Chronic Lower Back Pain Industry

North America holds the largest market share around 60% in the global industry. Market dominance is primarily driven by a high prevalence of advanced healthcare infrastructure. Chronic pain in the lower back impacts a large percentage of the population in the region. As per the American Association of Society, nearly 25% of U.S. adults experience lower back pain annually. The Centers for Disease Control and Prevention identifies musculoskeletal disorders, including chronic back pain, as one of the leading causes of disability in the United States. Additionally, the market is supported by the widespread use of advanced treatment modalities. They encompass minimally invasive interventions, spinal cord stimulators, and regenerative therapies such as stem cell therapy. Government initiatives and healthcare spending also play a major role, with the healthcare industry in the region spending huge sums on pain management.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Johnson & Johnson Services, Inc., Pfizer Inc., Vertebral Technologies, Inc., Merck & Co., Medtronic plc, Boston Scientific Corporation, Mesoblast Limited, Stayble Therapeutics, Eli Lilly and Company, NuVasive, OrthoPediatrics, Smith Nephew, Stryker, DePuy Synthes, Spinal Elements, and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & solution adoption?
5. How has the competition been shaping up across the regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?